OPKO Health - 30 Year Stock Price History | OPK
Historical daily share price chart and data for OPKO Health since 1995 adjusted for splits and dividends. The latest closing stock price for OPKO Health as of February 28, 2025 is 1.74.
- The all-time high OPKO Health stock closing price was 19.12 on June 03, 2015.
- The OPKO Health 52-week high stock price is 1.84, which is 5.7% above the current share price.
- The OPKO Health 52-week low stock price is 0.86, which is 50.6% below the current share price.
- The average OPKO Health stock price for the last 52 weeks is 1.42.
| OPKO Health Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 1.5636 | 1.4500 | 1.7400 | 1.4500 | 1.7400 | 18.37% |
| 2024 | 1.3315 | 1.5700 | 1.6800 | 0.8655 | 1.4700 | -2.65% |
| 2023 | 1.5303 | 1.2200 | 2.1700 | 1.0600 | 1.5100 | 20.80% |
| 2022 | 2.5910 | 4.9300 | 4.9300 | 1.0500 | 1.2500 | -74.01% |
| 2021 | 4.1099 | 4.2000 | 5.9900 | 3.3300 | 4.8100 | 21.77% |
| 2020 | 3.0656 | 1.4900 | 5.9550 | 1.1500 | 3.9500 | 168.71% |
| 2019 | 2.2225 | 3.2900 | 3.8300 | 1.4200 | 1.4700 | -51.16% |
| 2018 | 4.1177 | 4.9700 | 6.2900 | 2.4600 | 3.0100 | -38.57% |
| 2017 | 6.8778 | 9.0900 | 9.3800 | 4.6100 | 4.9000 | -47.31% |
| 2016 | 9.9056 | 10.0000 | 11.9100 | 7.6600 | 9.3000 | -7.46% |
| 2015 | 12.9449 | 9.9300 | 19.1200 | 8.4100 | 10.0500 | 0.60% |
| 2014 | 8.7105 | 8.4100 | 9.9900 | 7.5800 | 9.9900 | 18.36% |
| 2013 | 7.9517 | 5.0000 | 12.3500 | 5.0000 | 8.4400 | 75.47% |
| 2012 | 4.6262 | 4.8800 | 5.4800 | 4.0900 | 4.8100 | -1.84% |
| 2011 | 4.2107 | 3.9300 | 5.6600 | 3.2800 | 4.9000 | 33.51% |
| 2010 | 2.3495 | 1.9500 | 3.8800 | 1.6300 | 3.6700 | 100.55% |
| 2009 | 1.6651 | 1.5800 | 2.7600 | 0.6000 | 1.8300 | 12.96% |
| 2008 | 1.9220 | 2.8900 | 3.4000 | 1.0800 | 1.6200 | -43.16% |
| 2007 | 3.5006 | 0.9000 | 5.3500 | 0.9000 | 2.8500 | 235.29% |
| 2006 | 0.5766 | 0.4100 | 1.0400 | 0.3800 | 0.8500 | 107.32% |
| 2005 | 0.3967 | 0.3200 | 0.4700 | 0.3200 | 0.4100 | 20.59% |
| 2004 | 0.6651 | 0.8500 | 1.1400 | 0.3350 | 0.3400 | -62.18% |
| 2003 | 0.5503 | 0.4900 | 0.9900 | 0.3300 | 0.8990 | 156.86% |
| 2002 | 1.0891 | 3.2000 | 3.2000 | 0.3500 | 0.3500 | -89.49% |
| 2001 | 4.0984 | 7.1250 | 8.0000 | 2.2000 | 3.3300 | -54.85% |
| 2000 | 9.3672 | 7.8100 | 17.5000 | 5.0000 | 7.3750 | -1.67% |
| 1999 | 7.0873 | 7.3750 | 9.0000 | 5.4380 | 7.5000 | 9.09% |
| 1998 | 7.7877 | 7.0630 | 14.5000 | 3.2500 | 6.8750 | 0.00% |
| 1997 | 4.7071 | 2.3750 | 11.0600 | 2.3750 | 6.8750 | 224.29% |
| 1996 | 3.8806 | 4.2500 | 6.0000 | 2.0000 | 2.1200 | -50.12% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.174B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $210.506B | 96.57 |
| Thermo Fisher Scientific (TMO) | United States | $202.042B | 24.50 |
| Alcon (ALC) | Switzerland | $44.047B | 29.47 |
| Edwards Lifesciences (EW) | United States | $42.914B | 27.77 |
| IDEXX Laboratories (IDXX) | United States | $37.709B | 43.46 |
| DexCom (DXCM) | United States | $35.463B | 55.00 |
| IQVIA Holdings (IQV) | United States | $34.295B | 19.00 |
| Mettler-Toledo (MTD) | United States | $27.400B | 31.83 |
| Waters (WAT) | United States | $22.520B | 31.95 |
| STERIS (STE) | Ireland | $21.977B | 25.13 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.361B | 0.00 |
| Hologic (HOLX) | United States | $14.588B | 15.74 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.679B | 14.04 |
| Sysmex ADR (SSMXY) | Japan | $11.343B | 35.57 |
| Penumbra (PEN) | United States | $11.081B | 100.24 |
| Globus Medical (GMED) | United States | $10.896B | 25.48 |
| Masimo (MASI) | United States | $9.140B | 44.23 |
| Teleflex (TFX) | United States | $8.250B | 13.16 |
| Glaukos (GKOS) | United States | $6.850B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.269B | 23.96 |
| PROCEPT BioRobotics (PRCT) | United States | $3.400B | 0.00 |
| Veracyte (VCYT) | United States | $3.050B | 55.44 |
| LivaNova (LIVN) | United Kingdom | $2.688B | 15.52 |
| Nihon Kohden (NHNKY) | Japan | $2.652B | 14.49 |
| TransMedics (TMDX) | United States | $2.588B | 82.04 |
| Elekta AB (EKTAY) | Sweden | $2.198B | 19.76 |
| Tandem Diabetes Care (TNDM) | United States | $2.145B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.701B | 8.89 |
| Alphatec Holdings (ATEC) | United States | $1.526B | 0.00 |
| RxSight (RXST) | United States | $1.181B | 0.00 |
| Artivion (AORT) | United States | $1.167B | 111.40 |
| Pulse Biosciences (PLSE) | United States | $1.154B | 0.00 |
| Paragon 28 (FNA) | United States | $1.092B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.883B | 0.00 |
| AxoGen (AXGN) | United States | $0.793B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.791B | 17.30 |
| SiBone (SIBN) | United States | $0.733B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.718B | 12.21 |
| IRadimed (IRMD) | United States | $0.699B | 36.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.694B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.597B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.569B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.452B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.449B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.446B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.411B | 9.04 |
| AngioDynamics (ANGO) | United States | $0.408B | 0.00 |
| NeuroPace (NPCE) | United States | $0.404B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.86 |
| CVRx (CVRX) | United States | $0.343B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.261B | 0.00 |
| Inogen (INGN) | United States | $0.234B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| Accuray (ARAY) | United States | $0.212B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.192B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.169B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.151B | 0.00 |
| Neuronetics (STIM) | United States | $0.135B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.125B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.121B | 0.00 |
| LENSAR (LNSR) | United States | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| InspireMD (NSPR) | Israel | $0.097B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.093B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.085B | 12.98 |
| Lucid Diagnostics (LUCD) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.081B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.58 |
| Microbot Medical (MBOT) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |